Evaluation of a novel severe combined immunodeficiency mouse model for antiviral drug evaluation against Chandipura virus infection
Chandipura virus (CHPV) is a negative-sense single-stranded RNA virus known to cause fatal encephalitis outbreaks in the Indian subcontinent. The virus displays tropism towards the pediatric population and holds significant public health concerns. Currently, there is no specific, effective therapy f...
Saved in:
| Published in | Antiviral research Vol. 213; p. 105582 |
|---|---|
| Main Authors | , , , , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Netherlands
Elsevier B.V
01.05.2023
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Chandipura virus (CHPV) is a negative-sense single-stranded RNA virus known to cause fatal encephalitis outbreaks in the Indian subcontinent. The virus displays tropism towards the pediatric population and holds significant public health concerns. Currently, there is no specific, effective therapy for CHPV encephalitis. In this study, we evaluated a novel C.B-17 severe combined immunodeficiency (SCID) mouse model which can be used for pre-clinical antiviral evaluation. Inoculation of CHPV developed a lethal infection in our model. Plaque assay and immunohistochemistry detected increased viral loads and antigens in various organs, including the brain, spinal cord, adrenal glands, and whole blood. We further conducted a proof-of-concept evaluation of favipiravir in the SCID mouse model. Favipiravir treatment improved survival with pre-symptomatic (days 5–14) and post-symptomatic (days 9–18) treatment. Reduced viral loads were observed in whole blood, kidney/adrenal gland, and brain tissue with favipiravir treatment. The findings in this study demonstrate the utility of SCID mouse for in vivo drug efficacy evaluation and the potential efficacy of favipiravir against CHPV infection.
[Display omitted]
•Chandipura virus causes a lethal infection in severe combined immunodeficiency mice.•Favipiravir treatment improved survival in the novel mouse model.•The novel mouse model has utility in antiviral evaluation against Chandipura virus. |
|---|---|
| AbstractList | Chandipura virus (CHPV) is a negative-sense single-stranded RNA virus known to cause fatal encephalitis outbreaks in the Indian subcontinent. The virus displays tropism towards the pediatric population and holds significant public health concerns. Currently, there is no specific, effective therapy for CHPV encephalitis. In this study, we evaluated a novel C.B-17 severe combined immunodeficiency (SCID) mouse model which can be used for pre-clinical antiviral evaluation. Inoculation of CHPV developed a lethal infection in our model. Plaque assay and immunohistochemistry detected increased viral loads and antigens in various organs, including the brain, spinal cord, adrenal glands, and whole blood. We further conducted a proof-of-concept evaluation of favipiravir in the SCID mouse model. Favipiravir treatment improved survival with pre-symptomatic (days 5–14) and post-symptomatic (days 9–18) treatment. Reduced viral loads were observed in whole blood, kidney/adrenal gland, and brain tissue with favipiravir treatment. The findings in this study demonstrate the utility of SCID mouse for in vivo drug efficacy evaluation and the potential efficacy of favipiravir against CHPV infection.
[Display omitted]
•Chandipura virus causes a lethal infection in severe combined immunodeficiency mice.•Favipiravir treatment improved survival in the novel mouse model.•The novel mouse model has utility in antiviral evaluation against Chandipura virus. Chandipura virus (CHPV) is a negative-sense single-stranded RNA virus known to cause fatal encephalitis outbreaks in the Indian subcontinent. The virus displays tropism towards the pediatric population and holds significant public health concerns. Currently, there is no specific, effective therapy for CHPV encephalitis. In this study, we evaluated a novel C.B-17 severe combined immunodeficiency (SCID) mouse model which can be used for pre-clinical antiviral evaluation. Inoculation of CHPV developed a lethal infection in our model. Plaque assay and immunohistochemistry detected increased viral loads and antigens in various organs, including the brain, spinal cord, adrenal glands, and whole blood. We further conducted a proof-of-concept evaluation of favipiravir in the SCID mouse model. Favipiravir treatment improved survival with pre-symptomatic (days 5-14) and post-symptomatic (days 9-18) treatment. Reduced viral loads were observed in whole blood, kidney/adrenal gland, and brain tissue with favipiravir treatment. The findings in this study demonstrate the utility of SCID mouse for in vivo drug efficacy evaluation and the potential efficacy of favipiravir against CHPV infection. Chandipura virus (CHPV) is a negative-sense single-stranded RNA virus known to cause fatal encephalitis outbreaks in the Indian subcontinent. The virus displays tropism towards the pediatric population and holds significant public health concerns. Currently, there is no specific, effective therapy for CHPV encephalitis. In this study, we evaluated a novel C.B-17 severe combined immunodeficiency (SCID) mouse model which can be used for pre-clinical antiviral evaluation. Inoculation of CHPV developed a lethal infection in our model. Plaque assay and immunohistochemistry detected increased viral loads and antigens in various organs, including the brain, spinal cord, adrenal glands, and whole blood. We further conducted a proof-of-concept evaluation of favipiravir in the SCID mouse model. Favipiravir treatment improved survival with pre-symptomatic (days 5-14) and post-symptomatic (days 9-18) treatment. Reduced viral loads were observed in whole blood, kidney/adrenal gland, and brain tissue with favipiravir treatment. The findings in this study demonstrate the utility of SCID mouse for in vivo drug efficacy evaluation and the potential efficacy of favipiravir against CHPV infection.Chandipura virus (CHPV) is a negative-sense single-stranded RNA virus known to cause fatal encephalitis outbreaks in the Indian subcontinent. The virus displays tropism towards the pediatric population and holds significant public health concerns. Currently, there is no specific, effective therapy for CHPV encephalitis. In this study, we evaluated a novel C.B-17 severe combined immunodeficiency (SCID) mouse model which can be used for pre-clinical antiviral evaluation. Inoculation of CHPV developed a lethal infection in our model. Plaque assay and immunohistochemistry detected increased viral loads and antigens in various organs, including the brain, spinal cord, adrenal glands, and whole blood. We further conducted a proof-of-concept evaluation of favipiravir in the SCID mouse model. Favipiravir treatment improved survival with pre-symptomatic (days 5-14) and post-symptomatic (days 9-18) treatment. Reduced viral loads were observed in whole blood, kidney/adrenal gland, and brain tissue with favipiravir treatment. The findings in this study demonstrate the utility of SCID mouse for in vivo drug efficacy evaluation and the potential efficacy of favipiravir against CHPV infection. |
| ArticleNumber | 105582 |
| Author | Kato, Hirofumi Suzuki, Tadaki Saijo, Masayuki Ebihara, Hideki Nakajima, Nozomi Kawahara, Madoka Tobiume, Minoru Takayama-Ito, Mutsuyo Nakayama, Noriko Satoh, Masaaki Furuta, Yousuke Kitaura, Satoshi Komeno, Takashi Moriya, Kyoji |
| Author_xml | – sequence: 1 givenname: Satoshi orcidid: 0000-0001-7254-4582 surname: Kitaura fullname: Kitaura, Satoshi organization: Department of Virology I, National Institute of Infectious Diseases, Tokyo, Japan – sequence: 2 givenname: Minoru surname: Tobiume fullname: Tobiume, Minoru organization: Department of Pathology, National Institute of Infectious Diseases, Tokyo, Japan – sequence: 3 givenname: Madoka orcidid: 0000-0003-0718-3594 surname: Kawahara fullname: Kawahara, Madoka organization: Department of Virology I, National Institute of Infectious Diseases, Tokyo, Japan – sequence: 4 givenname: Masaaki surname: Satoh fullname: Satoh, Masaaki organization: Department of Virology I, National Institute of Infectious Diseases, Tokyo, Japan – sequence: 5 givenname: Hirofumi surname: Kato fullname: Kato, Hirofumi organization: Department of Virology I, National Institute of Infectious Diseases, Tokyo, Japan – sequence: 6 givenname: Noriko surname: Nakayama fullname: Nakayama, Noriko organization: Department of Virology I, National Institute of Infectious Diseases, Tokyo, Japan – sequence: 7 givenname: Nozomi surname: Nakajima fullname: Nakajima, Nozomi organization: FUJIFILM Toyama Chemical Co., Ltd., Toyama, Japan – sequence: 8 givenname: Takashi surname: Komeno fullname: Komeno, Takashi organization: FUJIFILM Toyama Chemical Co., Ltd., Toyama, Japan – sequence: 9 givenname: Yousuke surname: Furuta fullname: Furuta, Yousuke organization: FUJIFILM Toyama Chemical Co., Ltd., Toyama, Japan – sequence: 10 givenname: Tadaki orcidid: 0000-0002-3820-9542 surname: Suzuki fullname: Suzuki, Tadaki organization: Department of Pathology, National Institute of Infectious Diseases, Tokyo, Japan – sequence: 11 givenname: Kyoji orcidid: 0000-0001-9628-2724 surname: Moriya fullname: Moriya, Kyoji organization: Department of Infectious Diseases, The University of Tokyo Hospital, Tokyo, Japan – sequence: 12 givenname: Masayuki orcidid: 0000-0001-5458-7298 surname: Saijo fullname: Saijo, Masayuki organization: Department of Virology I, National Institute of Infectious Diseases, Tokyo, Japan – sequence: 13 givenname: Hideki orcidid: 0000-0002-2576-9735 surname: Ebihara fullname: Ebihara, Hideki email: hebihara@niid.go.jp organization: Department of Virology I, National Institute of Infectious Diseases, Tokyo, Japan – sequence: 14 givenname: Mutsuyo orcidid: 0000-0002-3805-4165 surname: Takayama-Ito fullname: Takayama-Ito, Mutsuyo email: mutsuito@niid.go.jp organization: Department of Virology I, National Institute of Infectious Diseases, Tokyo, Japan |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/36948302$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFkUtv3CAUhVGVqpmk_Qspy248xeAXiy6i0TSJFKmbdo0ucJ0ysmEKtqWs88fLZPKQsomQQELfOXDPOSMnPngk5GvJ1iUrm--7NfjJLS7CsOaMi3xb1x3_QFZl1_JCMtmckFUmm0LUFT8lZyntGGNNK7tP5FQ0suoE4yvysF1gmGFywdPQU6A-LDjQhAtGpCaM2nm01I3j7IPF3hmH3tzTMcwJ824z3IdIX75DbZzvKL66wh04nya6-Qveuv0cgWZwTtT5Hs0B-Uw-9jAk_PJ0npM_P7e_N9fF7a-rm83lbWEq0U5Fh1ZCW9dGQGO5tm1lSpBNibpCYaXRNZe2rzkXeZVS91potEIbYYG3DYhz8u3ou4_h34xpUqNLBocBPOZxFG8lYzWveJfRiyd01iNatY9uhHivnoPLwI8jYGJIKWKvjJseB54iuEGVTB2KUjv1kow6FKWORWV9-0b__MT7ysujEnNUi8Oo0mMnaF3MeSob3Lse_wFESLah |
| CitedBy_id | crossref_primary_10_1002_jmv_28960 crossref_primary_10_1002_jmv_28840 crossref_primary_10_1186_s12982_024_00379_4 crossref_primary_10_3390_pathogens13121110 |
| Cites_doi | 10.1016/S1473-3099(17)30677-1 10.1016/j.antiviral.2017.12.021 10.1186/1471-2334-8-168 10.1371/journal.pntd.0006313 10.1093/jac/dky560 10.1371/journal.pone.0008615 10.3390/v11090856 10.1111/j.1365-2915.2012.01034.x 10.1111/j.1600-0684.1993.tb00663.x 10.1016/j.antiviral.2018.01.011 10.1016/j.antiviral.2013.09.015 10.1371/journal.pntd.0006648 10.1128/AAC.46.4.977-981.2002 10.1016/0952-7915(91)90055-6 10.1016/j.antiviral.2019.104641 10.1128/JVI.02346-12 10.1083/jcb.90.2.435 10.1080/14787210.2019.1635009 10.1128/mSphere.00061-15 10.1371/journal.pntd.0006848 10.1002/jmv.21041 10.4269/ajtmh.2005.73.566 10.1093/infdis/jiac135 10.1016/S2055-6640(20)30016-9 10.1016/j.antiviral.2013.09.003 10.3390/jcm10020273 10.1016/j.actatropica.2012.06.001 10.1016/S0140-6736(15)60232-X 10.1038/s41598-021-90551-6 10.3389/fmicb.2018.01489 10.1007/BF00687461 10.1603/0022-2585-38.4.480 10.1016/j.antiviral.2017.12.020 10.1016/S0014-2999(03)01285-8 10.1007/s00401-018-1809-z 10.7589/0090-3558-10.3.279 10.1371/journal.pone.0206416 10.1016/S0140-6736(04)16982-1 10.1056/NEJM198707163170304 10.1186/s12987-022-00323-1 10.1007/s00415-020-09866-5 10.2183/pjab.93.027 10.1016/j.virusres.2020.198014 10.1016/j.autneu.2005.04.005 |
| ContentType | Journal Article |
| Copyright | 2023 Elsevier B.V. Copyright © 2023 Elsevier B.V. All rights reserved. |
| Copyright_xml | – notice: 2023 Elsevier B.V. – notice: Copyright © 2023 Elsevier B.V. All rights reserved. |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1016/j.antiviral.2023.105582 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Biology |
| EISSN | 1872-9096 |
| ExternalDocumentID | 36948302 10_1016_j_antiviral_2023_105582 S0166354223000608 |
| Genre | Research Support, Non-U.S. Gov't Journal Article |
| GroupedDBID | --- --K --M .GJ .~1 0R~ 1B1 1RT 1~. 1~5 23M 4.4 457 4G. 53G 5GY 5VS 7-5 71M 8P~ 9JM AAAJQ AACTN AAEDT AAEDW AAIAV AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AARKO AATCM AAXUO ABBQC ABFNM ABJNI ABLVK ABMAC ABMZM ABXDB ABYKQ ABZDS ACDAQ ACGFS ACIUM ACRLP ADBBV ADEZE ADMUD AEBSH AEKER AENEX AFFNX AFKWA AFTJW AFXIZ AGEKW AGHFR AGUBO AGYEJ AHHHB AIEXJ AIKHN AITUG AJBFU AJOXV AJRQY ALCLG ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ANZVX ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV C45 CJTIS CNWQP CS3 EBS EFJIC EFLBG EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HMG HVGLF HZ~ IHE J1W KOM LCYCR LUGTX M41 MO0 N9A O-L O9- OAUVE OGGZJ OVD OZT P-8 P-9 P2P PC. Q38 R2- RIG ROL RPZ SCC SDF SDG SDP SES SEW SIN SPCBC SSH SSI SSP SSZ T5K TEORI WUQ ZGI ZXP ~G- AATTM AAXKI AAYWO AAYXX ABWVN ACIEU ACRPL ACVFH ADCNI ADNMO AEIPS AEUPX AFJKZ AFPUW AGCQF AGQPQ AGRNS AIGII AIIUN AKBMS AKRWK AKYEP ANKPU APXCP CITATION CGR CUY CVF ECM EIF NPM 7X8 EFKBS |
| ID | FETCH-LOGICAL-c437t-8ed9a755c3a6d2bd74c1a961eb4e3d9cb529df522323219bfb3bed3bc3da276a3 |
| IEDL.DBID | .~1 |
| ISSN | 0166-3542 1872-9096 |
| IngestDate | Mon Jul 21 11:39:51 EDT 2025 Wed Feb 19 02:23:40 EST 2025 Thu Apr 24 22:57:18 EDT 2025 Tue Jul 01 01:32:14 EDT 2025 Fri Feb 23 02:34:44 EST 2024 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Keywords | Pediatric infectious disease Vesiculovirus CHPV SCID Favipiravir T-705 |
| Language | English |
| License | Copyright © 2023 Elsevier B.V. All rights reserved. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c437t-8ed9a755c3a6d2bd74c1a961eb4e3d9cb529df522323219bfb3bed3bc3da276a3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| ORCID | 0000-0001-7254-4582 0000-0003-0718-3594 0000-0001-5458-7298 0000-0002-3805-4165 0000-0002-3820-9542 0000-0002-2576-9735 0000-0001-9628-2724 |
| PMID | 36948302 |
| PQID | 2790052428 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_2790052428 pubmed_primary_36948302 crossref_citationtrail_10_1016_j_antiviral_2023_105582 crossref_primary_10_1016_j_antiviral_2023_105582 elsevier_sciencedirect_doi_10_1016_j_antiviral_2023_105582 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | May 2023 2023-05-00 20230501 |
| PublicationDateYYYYMMDD | 2023-05-01 |
| PublicationDate_xml | – month: 05 year: 2023 text: May 2023 |
| PublicationDecade | 2020 |
| PublicationPlace | Netherlands |
| PublicationPlace_xml | – name: Netherlands |
| PublicationTitle | Antiviral research |
| PublicationTitleAlternate | Antiviral Res |
| PublicationYear | 2023 |
| Publisher | Elsevier B.V |
| Publisher_xml | – name: Elsevier B.V |
| References | Chadha, Arankalle, Jadi, Joshi, Thakare, Mahadev, Mishra (bib10) 2005; 73 Kavathekar, Dhanavade, Sonawane, Balakrishnan (bib24) 2020; 285 Tani, Fukuma, Fukushi, Taniguchi, Yoshikawa, Iwata-Yoshikawa, Sato, Suzuki, Nagata, Hasegawa, Kawai, Uda, Morikawa, Shimojima, Watanabe, Saijo (bib46) 2016; 1 Fischer, Vetter, Bausch, Burgess, Davey, Fowler, Hayden, Jahrling, Kalil, Mayers, Mehta, Uyeki, Jacobs (bib12) 2018; 18 Verma, Ghosh, Basu (bib49) 2018; 9 Joshi, Parkar, Ansari, Vora, Talwar, Tiwaskar, Patil, Barkate (bib23) 2021; 102 Tandale, Tikute, Arankalle, Sathe, Joshi, Ranadive, Kanojia, Eshwarachary, Kumarswamy, Mishra (bib45) 2008; 80 Anukumar, Amirthalingam, Shelke, Gunjikar, Shewale (bib3) 2013; 6 Carrasco, Van De Kar (bib9) 2003; 463 Ogino, Fedorov, Adams, Okada, Ito, Sugiyama, Ogino (bib36) 2019 Hassanipour, Arab-Zozani, Amani, Heidarzad, Fathalipour, Martinez-de-Hoyo (bib19) 2021; 11 Adalja, Inglesby (bib1) 2019; 17 Furuta, Takahashi, Fukuda, Kuno, Kamiyama, Kozaki, Nomura, Egawa, Minami, Watanabe, Narita, Shiraki (bib14) 2002; 46 Peiris, Dittus, Ratnayake (bib38) 1993; 22 Kumar, Arankalle (bib27) 2010; 5 MacAulay, Keep, Zeuthen (bib31) 2022; 19 Bhatt, Rodrigues (bib5) 1967; 55 Wu, Tseng, Lin, Wei, Lee, Young (bib53) 2018; 12 Kemp, Causey, Setzer, Moore (bib26) 1974; 10 Rao, Basu, Wairagkar, Gore, Arankalle, Thakare, Jadi, Rao, Mishra (bib40) 2004; 364 Zhu, Zhang, He, Wong, Banadyga, Qiu (bib55) 2018; 151 (bib21) 2017 Maroli, Feliciangeli, Bichaud, Charrel, Gradoni (bib32) 2013; 27 Richardson, Ottaviani, Prelle, Stebbing, Casalini, Corbellino (bib41) 2020; 267 Weller, Sharp, Christodoulides, Carare, Mollgard (bib51) 2018; 135 Saker, Henry, Tomaszewski, Loukas, Iwanaga, Oskouian, Tubbs (bib43) 2016; 8 Anukumar, Mun (bib2) 2020 Lagocka, Dziedziejko, Klos, Pawlik (bib29) 2021; 10 Hayden, Lenk, Stonis, Oldham-Creamer, Kang, Epstein (bib20) 2022 Bixler, Bocan, Wells, Wetzel, Van Tongeren, Dong, Garza, Donnelly, Cazares, Nuss, Soloveva, Koistinen, Welch, Epstein, Liang, Giesing, Lenk, Bavari, Warren (bib6) 2018; 151 Bixler, Bocan, Wells, Wetzel, Van Tongeren, Garza, Donnelly, Cazares, Soloveva, Welch, Epstein, Liang, Giesing, Lenk, Bavari, Warren (bib7) 2018; 151 Tani, Komeno, Fukuma, Fukushi, Taniguchi, Shimojima, Uda, Morikawa, Nakajima, Furuta, Saijo (bib47) 2018; 13 Verma, Waghmare, Jachak, Philkhana, Reddy, Basu (bib50) 2018; 12 Furuta, Gowen, Takahashi, Shiraki, Smee, Barnard (bib15) 2013; 100 Furuta, Komeno, Nakamura (bib16) 2017; 93 London, Omotade, Mello, Keusch (bib30) 2018; 12 Freedman (bib13) 1987; 317 Schnitzer, Franke, Schachner (bib44) 1981; 90 Traore-Lamizana, Fontenille, Diallo, Ba, Zeller, Mondo, Adam, Thonon, Maiga (bib48) 2001; 38 Wong, Qiu (bib52) 2018; 39 Menghani, Chikhale, Raval, Wadibhasme, Khedekar (bib34) 2012; 124 Gurav, Tandale, Jadi, Gunjikar, Tikute, Jamgaonkar, Khadse, Jalgaonkar, Arankalle, Mishra (bib18) 2010; 132 Dhanda, Rodrigues, Ghosh (bib11) 1970; 58 Jortner, Bhatt, Solitare (bib22) 1973; 23 Baranovich, Wong, Armstrong, Marjuki, Webby, Webster, Govorkova (bib4) 2013; 87 Ghosh, Basu (bib17) 2017; 30 McCune (bib33) 1991; 3 Roy, Chakraborty, Polley, Chattopadhyay, Roy (bib42) 2013; 100 Bouazza, Treluyer, Foissac, Mentré, Taburet, Guedj, Anglaret, De Lamballerie, Keïta, Malvy, Frange (bib8) 2015; 385 Kumar, Jadi, Anakkathil, Tandale, Mishra, Arankalle (bib28) 2008; 8 Pascua, Marathe, Vogel, Webby, Govorkova (bib37) 2019; 74 Mravec (bib35) 2005; 120 Pilkington, Pepperrell, Hill (bib39) 2020; 6 Kemp (bib25) 1975; 52 Yamada, Noguchi, Kimitsuki, Kaimori, Saito, Komeno, Nakajima, Furuta, Nishizono (bib54) 2019; 172 Wong (10.1016/j.antiviral.2023.105582_bib52) 2018; 39 Wu (10.1016/j.antiviral.2023.105582_bib53) 2018; 12 Freedman (10.1016/j.antiviral.2023.105582_bib13) 1987; 317 Pilkington (10.1016/j.antiviral.2023.105582_bib39) 2020; 6 (10.1016/j.antiviral.2023.105582_bib21) 2017 Hassanipour (10.1016/j.antiviral.2023.105582_bib19) 2021; 11 Adalja (10.1016/j.antiviral.2023.105582_bib1) 2019; 17 Lagocka (10.1016/j.antiviral.2023.105582_bib29) 2021; 10 Verma (10.1016/j.antiviral.2023.105582_bib49) 2018; 9 Roy (10.1016/j.antiviral.2023.105582_bib42) 2013; 100 Dhanda (10.1016/j.antiviral.2023.105582_bib11) 1970; 58 Fischer (10.1016/j.antiviral.2023.105582_bib12) 2018; 18 Bixler (10.1016/j.antiviral.2023.105582_bib6) 2018; 151 Ogino (10.1016/j.antiviral.2023.105582_bib36) 2019 MacAulay (10.1016/j.antiviral.2023.105582_bib31) 2022; 19 Bixler (10.1016/j.antiviral.2023.105582_bib7) 2018; 151 Furuta (10.1016/j.antiviral.2023.105582_bib16) 2017; 93 Bouazza (10.1016/j.antiviral.2023.105582_bib8) 2015; 385 Kemp (10.1016/j.antiviral.2023.105582_bib26) 1974; 10 London (10.1016/j.antiviral.2023.105582_bib30) 2018; 12 Menghani (10.1016/j.antiviral.2023.105582_bib34) 2012; 124 Hayden (10.1016/j.antiviral.2023.105582_bib20) 2022 Traore-Lamizana (10.1016/j.antiviral.2023.105582_bib48) 2001; 38 Furuta (10.1016/j.antiviral.2023.105582_bib14) 2002; 46 Tani (10.1016/j.antiviral.2023.105582_bib46) 2016; 1 Anukumar (10.1016/j.antiviral.2023.105582_bib2) 2020 Tani (10.1016/j.antiviral.2023.105582_bib47) 2018; 13 Kavathekar (10.1016/j.antiviral.2023.105582_bib24) 2020; 285 Richardson (10.1016/j.antiviral.2023.105582_bib41) 2020; 267 Weller (10.1016/j.antiviral.2023.105582_bib51) 2018; 135 Carrasco (10.1016/j.antiviral.2023.105582_bib9) 2003; 463 Chadha (10.1016/j.antiviral.2023.105582_bib10) 2005; 73 Tandale (10.1016/j.antiviral.2023.105582_bib45) 2008; 80 Kemp (10.1016/j.antiviral.2023.105582_bib25) 1975; 52 Zhu (10.1016/j.antiviral.2023.105582_bib55) 2018; 151 Joshi (10.1016/j.antiviral.2023.105582_bib23) 2021; 102 Ghosh (10.1016/j.antiviral.2023.105582_bib17) 2017; 30 Pascua (10.1016/j.antiviral.2023.105582_bib37) 2019; 74 Peiris (10.1016/j.antiviral.2023.105582_bib38) 1993; 22 Baranovich (10.1016/j.antiviral.2023.105582_bib4) 2013; 87 Kumar (10.1016/j.antiviral.2023.105582_bib28) 2008; 8 Bhatt (10.1016/j.antiviral.2023.105582_bib5) 1967; 55 Mravec (10.1016/j.antiviral.2023.105582_bib35) 2005; 120 Anukumar (10.1016/j.antiviral.2023.105582_bib3) 2013; 6 Maroli (10.1016/j.antiviral.2023.105582_bib32) 2013; 27 Yamada (10.1016/j.antiviral.2023.105582_bib54) 2019; 172 Verma (10.1016/j.antiviral.2023.105582_bib50) 2018; 12 Rao (10.1016/j.antiviral.2023.105582_bib40) 2004; 364 Saker (10.1016/j.antiviral.2023.105582_bib43) 2016; 8 Gurav (10.1016/j.antiviral.2023.105582_bib18) 2010; 132 Schnitzer (10.1016/j.antiviral.2023.105582_bib44) 1981; 90 Furuta (10.1016/j.antiviral.2023.105582_bib15) 2013; 100 Kumar (10.1016/j.antiviral.2023.105582_bib27) 2010; 5 Jortner (10.1016/j.antiviral.2023.105582_bib22) 1973; 23 McCune (10.1016/j.antiviral.2023.105582_bib33) 1991; 3 |
| References_xml | – volume: 317 start-page: 141 year: 1987 end-page: 145 ident: bib13 article-title: Equipoise and the ethics of clinical research publication-title: N. Engl. J. Med. – volume: 102 start-page: 501 year: 2021 end-page: 508 ident: bib23 article-title: Role of favipiravir in the treatment of COVID-19 publication-title: Int. J. Infect. Dis. : IJID : official publication of the International Society for Infectious Diseases – volume: 90 start-page: 435 year: 1981 end-page: 447 ident: bib44 article-title: Immunocytochemical demonstration of vimentin in astrocytes and ependymal cells of developing and adult mouse nervous system publication-title: JCB (J. Cell Biol.) – volume: 285 year: 2020 ident: bib24 article-title: Role of cell surface vimentin in Chandipura virus replication in Neuro-2a cells publication-title: Virus Res. – volume: 58 start-page: 179 year: 1970 end-page: 180 ident: bib11 article-title: Isolation of Chandipura virus from sandflies in Aurangabad publication-title: Indian J. Med. Res. – volume: 267 start-page: 1880 year: 2020 end-page: 1882 ident: bib41 article-title: CNS penetration of potential anti-COVID-19 drugs publication-title: J. Neurol. – volume: 12 year: 2018 ident: bib53 article-title: ICR suckling mouse model of Zika virus infection for disease modeling and drug validation publication-title: PLoS Neglected Trop. Dis. – volume: 22 start-page: 240 year: 1993 end-page: 245 ident: bib38 article-title: Seroepidemiology of dengue and other arboviruses in a natural population of toque macaques (Macaca sinica) at Polonnaruwa, Sri Lanka publication-title: J. Med. Primatol. – volume: 11 year: 2021 ident: bib19 article-title: The efficacy and safety of Favipiravir in treatment of COVID-19: a systematic review and meta-analysis of clinical trials publication-title: Sci. Rep. – volume: 74 start-page: 1333 year: 2019 end-page: 1341 ident: bib37 article-title: Optimizing T-705 (favipiravir) treatment of severe influenza B virus infection in the immunocompromised mouse model publication-title: J. Antimicrob. Chemother. – volume: 8 start-page: 168 year: 2008 ident: bib28 article-title: Development and evaluation of a real-time one step reverse-transcriptase PCR for quantitation of Chandipura virus publication-title: BMC Infect. Dis. – volume: 8 start-page: e927 year: 2016 ident: bib43 article-title: The human central canal of the spinal cord: a comprehensive review of its anatomy, embryology, molecular development, variants, and pathology publication-title: Cureus – year: 2022 ident: bib20 article-title: Favipiravir treatment of uncomplicated influenza in adults: results of two phase 3, randomized, double-blind, placebo-controlled trials publication-title: J. Infect. Dis. – volume: 6 start-page: 45 year: 2020 end-page: 51 ident: bib39 article-title: A review of the safety of favipiravir – a potential treatment in the COVID-19 pandemic? publication-title: Journal of Virus Eradication – volume: 120 start-page: 10 year: 2005 end-page: 17 ident: bib35 article-title: A new focus on interoceptive properties of adrenal medulla publication-title: Auton. Neurosci. – volume: 73 start-page: 566 year: 2005 end-page: 570 ident: bib10 article-title: An outbreak of Chandipura virus encephalitis in the eastern districts of Gujarat state, India publication-title: Am. J. Trop. Med. Hyg. – volume: 23 start-page: 320 year: 1973 end-page: 325 ident: bib22 article-title: Experimental Chandipura virus infection in mice. I. Virus assay and light microscopic studies with emphasis on neuropathologic observations publication-title: Acta Neuropathol. – volume: 5 year: 2010 ident: bib27 article-title: Intracranial administration of P gene siRNA protects mice from lethal Chandipura virus encephalitis publication-title: PLoS One – volume: 364 start-page: 869 year: 2004 end-page: 874 ident: bib40 article-title: A large outbreak of acute encephalitis with high fatality rate in children in Andhra Pradesh, India, in 2003, associated with Chandipura virus publication-title: Lancet – volume: 132 start-page: 395 year: 2010 end-page: 399 ident: bib18 article-title: Chandipura virus encephalitis outbreak among children in Nagpur division, Maharashtra, 2007 publication-title: Indian J. Med. Res. – volume: 100 start-page: 446 year: 2013 end-page: 454 ident: bib15 article-title: Favipiravir (T-705), a novel viral RNA polymerase inhibitor publication-title: Antivir. Res. – volume: 12 year: 2018 ident: bib30 article-title: Ethics of randomized trials in a public health emergency publication-title: PLoS Neglected Trop. Dis. – year: 2017 ident: bib21 publication-title: Immunodeficient mice from Charles River Europe – volume: 80 start-page: 118 year: 2008 end-page: 124 ident: bib45 article-title: Chandipura virus: a major cause of acute encephalitis in children in North Telangana, Andhra Pradesh, India publication-title: J. Med. Virol. – volume: 10 year: 2021 ident: bib29 article-title: Favipiravir in therapy of viral infections publication-title: J. Clin. Med. – volume: 93 start-page: 449 year: 2017 end-page: 463 ident: bib16 article-title: Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase publication-title: Proc. Jpn. Acad. Series B – volume: 30 start-page: 21 year: 2017 end-page: 25 ident: bib17 article-title: Neuropathogenesis by Chandipura virus: an acute encephalitis syndrome in India publication-title: Natl. Med. J. India – volume: 100 start-page: 346 year: 2013 end-page: 355 ident: bib42 article-title: A peptide targeted against phosphoprotein and leader RNA interaction inhibits growth of Chandipura virus -- an emerging rhabdovirus publication-title: Antivir. Res. – volume: 18 start-page: e183 year: 2018 end-page: e192 ident: bib12 article-title: Ebola virus disease: an update on post-exposure prophylaxis publication-title: Lancet Infect. Dis. – volume: 87 start-page: 3741 year: 2013 end-page: 3751 ident: bib4 article-title: T-705 (favipiravir) induces lethal mutagenesis in influenza A H1N1 viruses in vitro publication-title: J. Virol. – volume: 52 start-page: 615 year: 1975 end-page: 620 ident: bib25 article-title: Viruses other than arenaviruses from West African wild mammals. Factors affecting transmission to man and domestic animals publication-title: Bull. World Health Organ. – volume: 9 start-page: 1489 year: 2018 ident: bib49 article-title: Chandipura virus induced neuronal apoptosis via calcium signaling mediated oxidative stress publication-title: Front. Microbiol. – volume: 6 start-page: 1272 year: 2013 end-page: 1281 ident: bib3 article-title: Neuro-invasion of Chandipura virus mediates pathogenesis in experimentally infected mice publication-title: Int. J. Clin. Exp. Pathol. – volume: 39 start-page: 3 year: 2018 end-page: 14 ident: bib52 article-title: Type I interferon receptor knockout mice as models for infection of highly pathogenic viruses with outbreak potential publication-title: Zool. Res. – year: 2020 ident: bib2 article-title: Ribavirin inhibits the Chandipura virus replication in Vero cells publication-title: J. Med. Virol. – volume: 12 year: 2018 ident: bib50 article-title: Nitrosporeusine analogue ameliorates Chandipura virus induced inflammatory response in CNS via NFkappab inactivation in microglia publication-title: PLoS Neglected Trop. Dis. – volume: 1 year: 2016 ident: bib46 article-title: Efficacy of T-705 (favipiravir) in the treatment of infections with lethal severe fever with thrombocytopenia syndrome virus publication-title: mSphere – volume: 55 start-page: 1295 year: 1967 end-page: 1305 ident: bib5 article-title: Chandipura: a new Arbovirus isolated in India from patients with febrile illness publication-title: Indian J. Med. Res. – volume: 172 year: 2019 ident: bib54 article-title: Reevaluation of the efficacy of favipiravir against rabies virus using in vivo imaging analysis publication-title: Antivir. Res. – volume: 17 start-page: 467 year: 2019 end-page: 470 ident: bib1 article-title: Broad-spectrum antiviral agents: a crucial pandemic tool publication-title: Expert Rev. Anti-infect. Ther. – volume: 19 start-page: 26 year: 2022 ident: bib31 article-title: Cerebrospinal fluid production by the choroid plexus: a century of barrier research revisited publication-title: Fluids Barriers CNS – volume: 151 start-page: 39 year: 2018 end-page: 49 ident: bib55 article-title: Successful treatment of Marburg virus with orally administrated T-705 (Favipiravir) in a mouse model publication-title: Antivir. Res. – volume: 135 start-page: 363 year: 2018 end-page: 385 ident: bib51 article-title: The meninges as barriers and facilitators for the movement of fluid, cells and pathogens related to the rodent and human CNS publication-title: Acta Neuropathol. – volume: 385 start-page: 603 year: 2015 end-page: 604 ident: bib8 article-title: Favipiravir for children with Ebola publication-title: Lancet – volume: 3 start-page: 224 year: 1991 end-page: 228 ident: bib33 article-title: SCID mice as immune system models publication-title: Curr. Opin. Immunol. – volume: 124 start-page: 1 year: 2012 end-page: 14 ident: bib34 article-title: Chandipura Virus: an emerging tropical pathogen publication-title: Acta Trop. – volume: 463 start-page: 235 year: 2003 end-page: 272 ident: bib9 article-title: Neuroendocrine pharmacology of stress publication-title: Eur. J. Pharmacol. – volume: 46 start-page: 977 year: 2002 end-page: 981 ident: bib14 article-title: In vitro and in vivo activities of anti-influenza virus compound T-705 publication-title: Antimicrob. Agents Chemother. – volume: 13 year: 2018 ident: bib47 article-title: Therapeutic effects of favipiravir against severe fever with thrombocytopenia syndrome virus infection in a lethal mouse model: dose-efficacy studies upon oral administration publication-title: PLoS One – volume: 151 start-page: 97 year: 2018 end-page: 104 ident: bib6 article-title: Efficacy of favipiravir (T-705) in nonhuman primates infected with Ebola virus or Marburg virus publication-title: Antivir. Res. – volume: 38 start-page: 480 year: 2001 end-page: 492 ident: bib48 article-title: Arbovirus surveillance from 1990 to 1995 in the Barkedji area (Ferlo) of Senegal, a possible natural focus of Rift Valley fever virus publication-title: J. Med. Entomol. – volume: 10 start-page: 279 year: 1974 end-page: 293 ident: bib26 article-title: Isolation of viruses from wild mammals in West Africa, 1966-1970 publication-title: J. Wildl. Dis. – volume: 27 start-page: 123 year: 2013 end-page: 147 ident: bib32 article-title: Phlebotomine sandflies and the spreading of leishmaniases and other diseases of public health concern publication-title: Med. Vet. Entomol. – volume: 151 start-page: 50 year: 2018 end-page: 54 ident: bib7 article-title: Intracellular conversion and in vivo dose response of favipiravir (T-705) in rodents infected with Ebola virus publication-title: Antivir. Res. – year: 2019 ident: bib36 article-title: Vesiculopolins, a new class of anti-vesiculoviral compounds, inhibit transcription initiation of vesiculoviruses publication-title: Viruses 11 – volume: 58 start-page: 179 year: 1970 ident: 10.1016/j.antiviral.2023.105582_bib11 article-title: Isolation of Chandipura virus from sandflies in Aurangabad publication-title: Indian J. Med. Res. – volume: 18 start-page: e183 year: 2018 ident: 10.1016/j.antiviral.2023.105582_bib12 article-title: Ebola virus disease: an update on post-exposure prophylaxis publication-title: Lancet Infect. Dis. doi: 10.1016/S1473-3099(17)30677-1 – volume: 151 start-page: 97 year: 2018 ident: 10.1016/j.antiviral.2023.105582_bib6 article-title: Efficacy of favipiravir (T-705) in nonhuman primates infected with Ebola virus or Marburg virus publication-title: Antivir. Res. doi: 10.1016/j.antiviral.2017.12.021 – volume: 8 start-page: 168 year: 2008 ident: 10.1016/j.antiviral.2023.105582_bib28 article-title: Development and evaluation of a real-time one step reverse-transcriptase PCR for quantitation of Chandipura virus publication-title: BMC Infect. Dis. doi: 10.1186/1471-2334-8-168 – volume: 102 start-page: 501 year: 2021 ident: 10.1016/j.antiviral.2023.105582_bib23 article-title: Role of favipiravir in the treatment of COVID-19 publication-title: Int. J. Infect. Dis. : IJID : official publication of the International Society for Infectious Diseases – volume: 12 year: 2018 ident: 10.1016/j.antiviral.2023.105582_bib30 article-title: Ethics of randomized trials in a public health emergency publication-title: PLoS Neglected Trop. Dis. doi: 10.1371/journal.pntd.0006313 – volume: 74 start-page: 1333 year: 2019 ident: 10.1016/j.antiviral.2023.105582_bib37 article-title: Optimizing T-705 (favipiravir) treatment of severe influenza B virus infection in the immunocompromised mouse model publication-title: J. Antimicrob. Chemother. doi: 10.1093/jac/dky560 – volume: 5 year: 2010 ident: 10.1016/j.antiviral.2023.105582_bib27 article-title: Intracranial administration of P gene siRNA protects mice from lethal Chandipura virus encephalitis publication-title: PLoS One doi: 10.1371/journal.pone.0008615 – volume: 39 start-page: 3 year: 2018 ident: 10.1016/j.antiviral.2023.105582_bib52 article-title: Type I interferon receptor knockout mice as models for infection of highly pathogenic viruses with outbreak potential publication-title: Zool. Res. – year: 2019 ident: 10.1016/j.antiviral.2023.105582_bib36 article-title: Vesiculopolins, a new class of anti-vesiculoviral compounds, inhibit transcription initiation of vesiculoviruses publication-title: Viruses 11 doi: 10.3390/v11090856 – volume: 132 start-page: 395 year: 2010 ident: 10.1016/j.antiviral.2023.105582_bib18 article-title: Chandipura virus encephalitis outbreak among children in Nagpur division, Maharashtra, 2007 publication-title: Indian J. Med. Res. – volume: 27 start-page: 123 year: 2013 ident: 10.1016/j.antiviral.2023.105582_bib32 article-title: Phlebotomine sandflies and the spreading of leishmaniases and other diseases of public health concern publication-title: Med. Vet. Entomol. doi: 10.1111/j.1365-2915.2012.01034.x – volume: 22 start-page: 240 year: 1993 ident: 10.1016/j.antiviral.2023.105582_bib38 article-title: Seroepidemiology of dengue and other arboviruses in a natural population of toque macaques (Macaca sinica) at Polonnaruwa, Sri Lanka publication-title: J. Med. Primatol. doi: 10.1111/j.1600-0684.1993.tb00663.x – volume: 151 start-page: 39 year: 2018 ident: 10.1016/j.antiviral.2023.105582_bib55 article-title: Successful treatment of Marburg virus with orally administrated T-705 (Favipiravir) in a mouse model publication-title: Antivir. Res. doi: 10.1016/j.antiviral.2018.01.011 – volume: 100 start-page: 446 year: 2013 ident: 10.1016/j.antiviral.2023.105582_bib15 article-title: Favipiravir (T-705), a novel viral RNA polymerase inhibitor publication-title: Antivir. Res. doi: 10.1016/j.antiviral.2013.09.015 – volume: 12 year: 2018 ident: 10.1016/j.antiviral.2023.105582_bib50 article-title: Nitrosporeusine analogue ameliorates Chandipura virus induced inflammatory response in CNS via NFkappab inactivation in microglia publication-title: PLoS Neglected Trop. Dis. doi: 10.1371/journal.pntd.0006648 – volume: 46 start-page: 977 year: 2002 ident: 10.1016/j.antiviral.2023.105582_bib14 article-title: In vitro and in vivo activities of anti-influenza virus compound T-705 publication-title: Antimicrob. Agents Chemother. doi: 10.1128/AAC.46.4.977-981.2002 – volume: 3 start-page: 224 year: 1991 ident: 10.1016/j.antiviral.2023.105582_bib33 article-title: SCID mice as immune system models publication-title: Curr. Opin. Immunol. doi: 10.1016/0952-7915(91)90055-6 – volume: 172 year: 2019 ident: 10.1016/j.antiviral.2023.105582_bib54 article-title: Reevaluation of the efficacy of favipiravir against rabies virus using in vivo imaging analysis publication-title: Antivir. Res. doi: 10.1016/j.antiviral.2019.104641 – volume: 87 start-page: 3741 year: 2013 ident: 10.1016/j.antiviral.2023.105582_bib4 article-title: T-705 (favipiravir) induces lethal mutagenesis in influenza A H1N1 viruses in vitro publication-title: J. Virol. doi: 10.1128/JVI.02346-12 – year: 2017 ident: 10.1016/j.antiviral.2023.105582_bib21 – volume: 90 start-page: 435 year: 1981 ident: 10.1016/j.antiviral.2023.105582_bib44 article-title: Immunocytochemical demonstration of vimentin in astrocytes and ependymal cells of developing and adult mouse nervous system publication-title: JCB (J. Cell Biol.) doi: 10.1083/jcb.90.2.435 – volume: 17 start-page: 467 year: 2019 ident: 10.1016/j.antiviral.2023.105582_bib1 article-title: Broad-spectrum antiviral agents: a crucial pandemic tool publication-title: Expert Rev. Anti-infect. Ther. doi: 10.1080/14787210.2019.1635009 – volume: 1 year: 2016 ident: 10.1016/j.antiviral.2023.105582_bib46 article-title: Efficacy of T-705 (favipiravir) in the treatment of infections with lethal severe fever with thrombocytopenia syndrome virus publication-title: mSphere doi: 10.1128/mSphere.00061-15 – volume: 12 year: 2018 ident: 10.1016/j.antiviral.2023.105582_bib53 article-title: ICR suckling mouse model of Zika virus infection for disease modeling and drug validation publication-title: PLoS Neglected Trop. Dis. doi: 10.1371/journal.pntd.0006848 – volume: 80 start-page: 118 year: 2008 ident: 10.1016/j.antiviral.2023.105582_bib45 article-title: Chandipura virus: a major cause of acute encephalitis in children in North Telangana, Andhra Pradesh, India publication-title: J. Med. Virol. doi: 10.1002/jmv.21041 – volume: 73 start-page: 566 year: 2005 ident: 10.1016/j.antiviral.2023.105582_bib10 article-title: An outbreak of Chandipura virus encephalitis in the eastern districts of Gujarat state, India publication-title: Am. J. Trop. Med. Hyg. doi: 10.4269/ajtmh.2005.73.566 – year: 2020 ident: 10.1016/j.antiviral.2023.105582_bib2 article-title: Ribavirin inhibits the Chandipura virus replication in Vero cells publication-title: J. Med. Virol. – year: 2022 ident: 10.1016/j.antiviral.2023.105582_bib20 article-title: Favipiravir treatment of uncomplicated influenza in adults: results of two phase 3, randomized, double-blind, placebo-controlled trials publication-title: J. Infect. Dis. doi: 10.1093/infdis/jiac135 – volume: 6 start-page: 45 year: 2020 ident: 10.1016/j.antiviral.2023.105582_bib39 article-title: A review of the safety of favipiravir – a potential treatment in the COVID-19 pandemic? publication-title: Journal of Virus Eradication doi: 10.1016/S2055-6640(20)30016-9 – volume: 100 start-page: 346 year: 2013 ident: 10.1016/j.antiviral.2023.105582_bib42 article-title: A peptide targeted against phosphoprotein and leader RNA interaction inhibits growth of Chandipura virus -- an emerging rhabdovirus publication-title: Antivir. Res. doi: 10.1016/j.antiviral.2013.09.003 – volume: 10 year: 2021 ident: 10.1016/j.antiviral.2023.105582_bib29 article-title: Favipiravir in therapy of viral infections publication-title: J. Clin. Med. doi: 10.3390/jcm10020273 – volume: 30 start-page: 21 year: 2017 ident: 10.1016/j.antiviral.2023.105582_bib17 article-title: Neuropathogenesis by Chandipura virus: an acute encephalitis syndrome in India publication-title: Natl. Med. J. India – volume: 124 start-page: 1 year: 2012 ident: 10.1016/j.antiviral.2023.105582_bib34 article-title: Chandipura Virus: an emerging tropical pathogen publication-title: Acta Trop. doi: 10.1016/j.actatropica.2012.06.001 – volume: 55 start-page: 1295 year: 1967 ident: 10.1016/j.antiviral.2023.105582_bib5 article-title: Chandipura: a new Arbovirus isolated in India from patients with febrile illness publication-title: Indian J. Med. Res. – volume: 52 start-page: 615 year: 1975 ident: 10.1016/j.antiviral.2023.105582_bib25 article-title: Viruses other than arenaviruses from West African wild mammals. Factors affecting transmission to man and domestic animals publication-title: Bull. World Health Organ. – volume: 385 start-page: 603 year: 2015 ident: 10.1016/j.antiviral.2023.105582_bib8 article-title: Favipiravir for children with Ebola publication-title: Lancet doi: 10.1016/S0140-6736(15)60232-X – volume: 11 year: 2021 ident: 10.1016/j.antiviral.2023.105582_bib19 article-title: The efficacy and safety of Favipiravir in treatment of COVID-19: a systematic review and meta-analysis of clinical trials publication-title: Sci. Rep. doi: 10.1038/s41598-021-90551-6 – volume: 9 start-page: 1489 year: 2018 ident: 10.1016/j.antiviral.2023.105582_bib49 article-title: Chandipura virus induced neuronal apoptosis via calcium signaling mediated oxidative stress publication-title: Front. Microbiol. doi: 10.3389/fmicb.2018.01489 – volume: 23 start-page: 320 year: 1973 ident: 10.1016/j.antiviral.2023.105582_bib22 article-title: Experimental Chandipura virus infection in mice. I. Virus assay and light microscopic studies with emphasis on neuropathologic observations publication-title: Acta Neuropathol. doi: 10.1007/BF00687461 – volume: 8 start-page: e927 year: 2016 ident: 10.1016/j.antiviral.2023.105582_bib43 article-title: The human central canal of the spinal cord: a comprehensive review of its anatomy, embryology, molecular development, variants, and pathology publication-title: Cureus – volume: 38 start-page: 480 year: 2001 ident: 10.1016/j.antiviral.2023.105582_bib48 article-title: Arbovirus surveillance from 1990 to 1995 in the Barkedji area (Ferlo) of Senegal, a possible natural focus of Rift Valley fever virus publication-title: J. Med. Entomol. doi: 10.1603/0022-2585-38.4.480 – volume: 151 start-page: 50 year: 2018 ident: 10.1016/j.antiviral.2023.105582_bib7 article-title: Intracellular conversion and in vivo dose response of favipiravir (T-705) in rodents infected with Ebola virus publication-title: Antivir. Res. doi: 10.1016/j.antiviral.2017.12.020 – volume: 463 start-page: 235 year: 2003 ident: 10.1016/j.antiviral.2023.105582_bib9 article-title: Neuroendocrine pharmacology of stress publication-title: Eur. J. Pharmacol. doi: 10.1016/S0014-2999(03)01285-8 – volume: 135 start-page: 363 year: 2018 ident: 10.1016/j.antiviral.2023.105582_bib51 article-title: The meninges as barriers and facilitators for the movement of fluid, cells and pathogens related to the rodent and human CNS publication-title: Acta Neuropathol. doi: 10.1007/s00401-018-1809-z – volume: 10 start-page: 279 year: 1974 ident: 10.1016/j.antiviral.2023.105582_bib26 article-title: Isolation of viruses from wild mammals in West Africa, 1966-1970 publication-title: J. Wildl. Dis. doi: 10.7589/0090-3558-10.3.279 – volume: 13 year: 2018 ident: 10.1016/j.antiviral.2023.105582_bib47 article-title: Therapeutic effects of favipiravir against severe fever with thrombocytopenia syndrome virus infection in a lethal mouse model: dose-efficacy studies upon oral administration publication-title: PLoS One doi: 10.1371/journal.pone.0206416 – volume: 364 start-page: 869 year: 2004 ident: 10.1016/j.antiviral.2023.105582_bib40 article-title: A large outbreak of acute encephalitis with high fatality rate in children in Andhra Pradesh, India, in 2003, associated with Chandipura virus publication-title: Lancet doi: 10.1016/S0140-6736(04)16982-1 – volume: 317 start-page: 141 year: 1987 ident: 10.1016/j.antiviral.2023.105582_bib13 article-title: Equipoise and the ethics of clinical research publication-title: N. Engl. J. Med. doi: 10.1056/NEJM198707163170304 – volume: 6 start-page: 1272 year: 2013 ident: 10.1016/j.antiviral.2023.105582_bib3 article-title: Neuro-invasion of Chandipura virus mediates pathogenesis in experimentally infected mice publication-title: Int. J. Clin. Exp. Pathol. – volume: 19 start-page: 26 year: 2022 ident: 10.1016/j.antiviral.2023.105582_bib31 article-title: Cerebrospinal fluid production by the choroid plexus: a century of barrier research revisited publication-title: Fluids Barriers CNS doi: 10.1186/s12987-022-00323-1 – volume: 267 start-page: 1880 year: 2020 ident: 10.1016/j.antiviral.2023.105582_bib41 article-title: CNS penetration of potential anti-COVID-19 drugs publication-title: J. Neurol. doi: 10.1007/s00415-020-09866-5 – volume: 93 start-page: 449 year: 2017 ident: 10.1016/j.antiviral.2023.105582_bib16 article-title: Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase publication-title: Proc. Jpn. Acad. Series B doi: 10.2183/pjab.93.027 – volume: 285 year: 2020 ident: 10.1016/j.antiviral.2023.105582_bib24 article-title: Role of cell surface vimentin in Chandipura virus replication in Neuro-2a cells publication-title: Virus Res. doi: 10.1016/j.virusres.2020.198014 – volume: 120 start-page: 10 year: 2005 ident: 10.1016/j.antiviral.2023.105582_bib35 article-title: A new focus on interoceptive properties of adrenal medulla publication-title: Auton. Neurosci. doi: 10.1016/j.autneu.2005.04.005 |
| SSID | ssj0006798 |
| Score | 2.4232929 |
| Snippet | Chandipura virus (CHPV) is a negative-sense single-stranded RNA virus known to cause fatal encephalitis outbreaks in the Indian subcontinent. The virus... |
| SourceID | proquest pubmed crossref elsevier |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 105582 |
| SubjectTerms | Animals Antiviral Agents - therapeutic use Child CHPV Drug Evaluation Encephalitis Favipiravir Humans Mice Mice, SCID Pediatric infectious disease SCID Severe Combined Immunodeficiency - drug therapy T-705 Vesiculovirus Vesiculovirus - genetics |
| Title | Evaluation of a novel severe combined immunodeficiency mouse model for antiviral drug evaluation against Chandipura virus infection |
| URI | https://dx.doi.org/10.1016/j.antiviral.2023.105582 https://www.ncbi.nlm.nih.gov/pubmed/36948302 https://www.proquest.com/docview/2790052428 |
| Volume | 213 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LbxQxDLaqIhAXBOXR5VEZieuw3UlmsuFWVa0WUHuBSr1FeXiqQdXsatlF4sKFP449r6qHqgc0p4mSycOe2IntzwAfomKpH4tD1twoZJqUz4IxVUbWhlmyLJDadD5n5-XiQn-5LC534HiIhRG3yn7v7_b0drfuS6b9ak5XdT39xsoKS0vNn2tRRSTgV2sjXP7xz42bh1gZOnzvMpPat3y8ePC1-NKKDSJXkvO2mOd3Sai7NNBWEp0-hSe9ColH3SifwQ41e_CwSyr5ew8enfXm8ufw92TE8sZlhR6b5S-6Ru6K1oQ8ZT4WU8JaYkSWiQRMQiIxUa4DCNskOchKLY4TwLTeXuENQjj6K1-zgokSpJDq1XbtkStuf-Lg5NW8gIvTk-_Hi6zPupBFrcwmm1Oy3hRFVL5MeUhGx5m35YwCUzLZGIrcporVNsXPzIYqqEBJhaiSz03p1UvYbZYN7QMGwyWaTDLB6Cr3vioESyapaDX5eZxAOay0iz0kuWTGuHaD79kPN87QCYlcR6IJHI4NVx0qx_1NPg2kdLcYzLHsuL_x-4H4jn8_san4hpgWLjdWbtb5EDeBVx1XjCNSpdUCr_b6f7p-A4_lrfOxfAu7m_WW3rEetAkHLaMfwIOjz18X5_8AUwELkw |
| linkProvider | Elsevier |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9swDCa6FHtchq17pes2DtjVSGPJVrRbUbRI1yaXtUBvgl4uPBROkCYFdt4fH-lX0UPRQ-GbbNqSKJOUSH4E-OEFaX2f7ZPlFl0io7CJU6pIotZuHDQppLqcz2yeTy_kr8vscgsOu1wYDqtsZX8j02tp3baM2tkcLcty9JuMFdKWkl5Xo4pMnsE2o1NlA9g-ODmdznuBzI6GBuI7T5jgXpgX9b_kcFp2Q6SCy95mk_QhJfWQEVoro-M38Lq1IvGg6ehb2IrVDjxv6kr-3YEXs9Zj_g7-HfVw3rgo0GK1uI3XSJ-Kq4g0atoZx4Alp4ksQmQ8CU7GRD4RiFjXyUGya7EfAIbV5grvQMLRXtmSbEzkPIVQLjcri_Tg5ga7OK_qPVwcH50fTpO28ELipVDrZBKDtirLvLB5SF1Q0o-tzsfRETOD9i5LdSjIchN0jbUrnHAxCOdFsKnKrfgAg2pRxU-ATlGLjCoop2SRWltkDCcThNcy2okfQt7NtPEtKjkXx7g2XfjZH9OP0DCLTMOiIez3hMsGmONxkp8dK829NWZIfTxO_L1jvqE_kN0qtorEC5MqzYfrtI8bwsdmVfQ9ErmWjLC2-5RPf4OX0_PZmTk7mZ9-hld8pwm53IPBerWJX8gsWruv7bL_D2lwDkQ |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Evaluation+of+a+novel+severe+combined+immunodeficiency+mouse+model+for+antiviral+drug+evaluation+against+Chandipura+virus+infection&rft.jtitle=Antiviral+research&rft.au=Kitaura%2C+Satoshi&rft.au=Tobiume%2C+Minoru&rft.au=Kawahara%2C+Madoka&rft.au=Satoh%2C+Masaaki&rft.date=2023-05-01&rft.eissn=1872-9096&rft.volume=213&rft.spage=105582&rft_id=info:doi/10.1016%2Fj.antiviral.2023.105582&rft_id=info%3Apmid%2F36948302&rft.externalDocID=36948302 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0166-3542&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0166-3542&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0166-3542&client=summon |